Seres Therapeutics, Inc. (MCRB) — SC 13D/A Filings
All SC 13D/A filings from Seres Therapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Nestlé Amends Seres Therapeutics Stake Filing
— Oct 2, 2024 Risk: medium
Nestlé S.A. has filed an amendment (No. 3) to its Schedule 13D/A for Seres Therapeutics, Inc. on October 2, 2024. The filing indicates changes in beneficial own
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX